FDA recall record

Pegasus Foods Cream Cheese Rangoon NET WT: 5.00 LB recall — FDA F-1501-2023

Plastic foreign object found in product.

Class IIclassification
F-1501-2023official record ID
Sep 20, 2023report date

Recall record at a glance

Official recordF-1501-2023
CategoryFood Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmPegasus Foods, Inc.
Report dateSep 20, 2023
Recall initiation dateJun 26, 2023
Quantity38,887 cs. / 193,435 lbs.
LocationRockwall, TX, United States

Official product description

Cream Cheese Rangoon NET WT: 5.00 LB. (2.26 KG) CT/CS: 100 PS (5 TRAYS X 20 PCS UPC: (01)10664383187016(15)112823(10)0601233A1W package in corrugated cardboard case.

Why the product was recalled

Plastic foreign object found in product.

Distribution information

CA

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.